As incentive compensation continues to be an integral part of the total compensation package for executives at publicly traded companies, A&M's Executive Compensation and Benefits Practice has conducted an analysis of the compensation arrangements at the 100 largest U.S. exploration and production companies.

Donald Trump’s “Healthcare Reform [plan] to Make America Great Again” initially focused on a complete repeal of Obamacare; it has now morphed into “Repeal and replace” with a timeline estimated by various pundits at 2-3 years.

The U.S. healthcare system is not yet prepared for the influx of aging Baby Boomers and their medical, behavioral, functional and social needs. Embedded inefficiencies exist. Facility-centric care predominates. However, a glimmer of change driven by patient-centric payment reform has begun to emerge. Read our report for perspective on the rapidly aging U.S. population, the evolution of payment reform and the implications of all the changes to the post-acute care sector.

Mergers and acquisitions continue to flourish within the pharmaceutical industry. Are multinational pharmaceutical enterprises still able to generate tax savings through IP migration to Ireland, in light of the OECD action plan to combat base erosion and profit shifting?